Institutional & Family Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$34.3K Sell
166
-4
-2% -$906 0.01% 282
2024
Q1
$46.1K Sell
170
-9
-5% -$2.15K 0.01% 242
2023
Q4
$42.3K Sell
179
-2
-1% -$393 0.01% 251
2023
Q3
$35.5K Hold
181
0.01% 246
2023
Q2
$38.1K Buy
181
+22
+14% +$4.38K 0.01% 247
2023
Q1
$32.1K Sell
159
-1
-0.6% -$227 0.01% 254
2022
Q4
$34.9K Buy
160
+7
+5% +$1.53K 0.01% 252
2022
Q3
$30K Hold
153
0.01% 266
2022
Q2
$33K Buy
153
+28
+22% +$6.84K 0.01% 260
2022
Q1
$35K Buy
125
+19
+18% +$5.86K 0.01% 287
2021
Q4
$40K Buy
+106
New +$41.2K 0.01% 287
2019
Q4
Sell
-14
Closed -$2K 860
2019
Q3
$2K Sell
14
-15
-52% -$2.01K ﹤0.01% 681
2019
Q2
$4K Buy
29
+24
+480% +$3.25K ﹤0.01% 616
2019
Q1
$1K Buy
+5
New +$657 ﹤0.01% 778

Other funds holding CRL